Korea FDA Director Encourages More Joint Research Deals With MNCs - PharmAsia Summit
This article was originally published in PharmAsia News
Executive Summary
SAN FRANCISCO - Establishing more joint research collaborations among multinational pharma companies and Korean hospitals, research centers and local companies will be one of the key goals Korea FDA will pursue in coming years, Hong Soon-Wook, KFDA's Pharmaceutical Safety Policy Division Director told Elsevier Business Intelligence's PharmaAsia Summit, Oct. 25 in San Francisco
You may also be interested in...
Korea FDA Prepares Guidelines On Phase 0 Clinical Trials To Draw More Early-stage Trials
SEOUL - Korea FDA is gearing up to release guidelines on Phase 0 clinical trials in the first half of next year under its broader ambition to draw more early-stage clinical trials to the country
Korea FDA Prepares Guidelines On Phase 0 Clinical Trials To Draw More Early-stage Trials
SEOUL - Korea FDA is gearing up to release guidelines on Phase 0 clinical trials in the first half of next year under its broader ambition to draw more early-stage clinical trials to the country
Korean Government Takes Precautionary Steps Against Pandemic Repeat
SEOUL - Hoping to avoid a recurrence of the influenza A/H1N1 pandemic from a year ago, South Korea's Ministry of Health and Welfare called on the country's senior citizens and the underprivileged to get free-of-charge flu vaccines beginning early October